# Evaluation of the 18F-PSMA Positron Emission Tomography (PET)/CT in Patients With Medullary Thyroid Cancer

> **NCT05534594** · NA · COMPLETED · sponsor: **University Medical Center Groningen** · enrollment: 8 (actual)

## Conditions studied

- Medullary Thyroid Cancer
- Medullary Thyroid Carcinoma
- Thyroid Carcinoma, Medullary
- Thyroid Cancer, Medullary

## Interventions

- **DRUG:** 18F-PSMA-1007

## Key facts

- **NCT ID:** NCT05534594
- **Lead sponsor:** University Medical Center Groningen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-08-19
- **Primary completion:** 2024-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2025-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05534594

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05534594, "Evaluation of the 18F-PSMA Positron Emission Tomography (PET)/CT in Patients With Medullary Thyroid Cancer". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT05534594. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*